Global legal access atlas
Every legal cannabis market. Correctly classified.
VeedAtlas separates licensed retail from medical prescriptions, non-profit associations, controlled pilots, tolerated sales, and private-use laws. “Decriminalized” alone does not make a market.
Retailer, pharmacy, licensed association, controlled trial, or expressly permitted private possession or cultivation.
Those policies may support an industry, but they do not give a consumer a lawful cannabis access route.
Interactive access map
See where every legal route exists.
53 of 53 country markets shown. Select a region to open its directory, or choose a country point to view its verified market profile.
Current selection
53 verified markets
Legal status checked against government, medicines-agency, regulator, or official legislative sources. Last full review: 27 August 2026.
North America
3 marketsUnited States
State-regulated markets; federal controls still applyCannabis access is regulated state by state. Twenty-four states, three territories, and Washington, DC allow or regulate non-medical adult use; 41 states, three territories, and DC allow medical use.
Canada
Nationally legal, provincially distributedAdults can legally buy cannabis from provincially or territorially authorized retailers. Federal law controls production and product rules; each province and territory controls distribution and sale.
Mexico
Medical framework; personal adult use requires authorizationMexico regulates cannabis and pharmacological derivatives for medical use. Supreme Court rulings created a route for personal adult-use authorizations, but there is no national licensed adult-use retail market.
South America
8 marketsUruguay
National regulated adult-use systemRegistered adults can access regulated cannabis through participating pharmacies, membership clubs, or registered home cultivation. Uruguay also regulates cannabis for medical use.
Argentina
Medical products and registered therapeutic cultivationPatients with a medical indication can access registered products, pharmacy-compounded formulations, or authorized controlled cultivation through REPROCANN.
Brazil
Prescription cannabis products under ANVISA rulesANVISA authorizes regulated cannabis products for human medical use, including pharmacy distribution and controlled import routes under the current framework.
Chile
Prescription and individual import pathwaysCannabis-based pharmaceutical products can be dispensed under retained prescription controls, and the health authority provides an individual import process for prescribed products.
Colombia
Regulated medical and scientific marketColombia has a licensing and product framework for safe, informed medical and scientific access, including nationally supplied finished medical products.
Ecuador
Therapeutic prescription and dispensing frameworkEcuador regulates therapeutic use, prescribing, and dispensing of medical cannabis and pharmaceutical cannabinoid products.
Peru
Licensed medical retail and associative cultivationPeru permits registered cannabis medicines, exceptional patient imports, pharmacy-compounded preparations, and licensed associative cultivation for qualified patients.
Paraguay
Registered medical products and patient programParaguay regulates psychoactive cannabis-derived products for medical use and maintains a national registry for doctors and patients through PROINCUMEC.
Central America
2 marketsCosta Rica
Licensed medical products and pharmacy dispensingCosta Rica regulates dried cannabis and dose-form medical products. Approved products containing THC can be dispensed by pharmacies against a digital prescription.
Panama
Medical patient registry and controlled dispensingPanama is implementing its national medicinal cannabis program with patient certification, medical supervision, product controls, and licensed dispensing.
Caribbean
5 marketsAntigua and Barbuda
Medical card and licensed dispensary marketThe Medicinal Cannabis Authority registers patients and regulates licensed cultivation, products, dispensaries, and therapeutic access.
Barbados
Prescription medicinal cannabis industryLicensed pharmacies and therapeutic facilities may dispense authorized medicinal cannabis to patients against a prescription and valid identification.
Grenada
Licensed medicinal cannabis frameworkGrenada provides a licensing framework for medicinal cannabis supply activities, including cultivation, manufacturing, dispensing, and sale.
Jamaica
Licensed medical and therapeutic cannabis industryJamaica licenses cannabis cultivation, processing, retail, and therapeutic services. Limited home cultivation is recognized while unauthorized general sale remains unlawful.
Saint Vincent and the Grenadines
Medical prescriptions, pharmacies, and patient accessAuthorized clinicians can prescribe medicinal cannabis and licensed pharmacies can dispense it to registered patients and eligible visiting patients.
Europe
22 marketsFrance
Restricted transitional medical accessFrance has a cannabis-medicine framework in its Public Health Code and a tightly restricted transition route for patients from the national medical cannabis experiment while the permanent system is completed.
Germany
Medical pharmacies, private cultivation, and non-profit associationsGermany permits prescribed medical cannabis, limited adult possession and home cultivation, and regulated non-commercial cultivation associations.
Netherlands
Tolerated coffeeshop sales and a controlled supply experimentCoffeeshop sales operate under a tolerance policy, not full national legalization. Ten municipalities participate in a government experiment with regulated production, distribution, and coffeeshop sale.
Malta
Resident-only non-profit associations and private cultivationAdults resident in Malta can join licensed non-profit cannabis harm-reduction associations. The law also permits limited private possession and home cultivation.
Luxembourg
Private home cultivation; no adult-use retailAdults may cultivate up to four plants per household and consume cannabis privately. Luxembourg also operates a medical cannabis program.
Czechia
Medical pharmacies and limited personal cultivationCzechia permits prescription medical cannabis. From January 2026, adults 21 and older may possess limited quantities and cultivate up to three plants for personal use.
Switzerland
Medical prescriptions and authorized adult-use pilot trialsMedical cannabis may be prescribed. Separate authorized scientific pilots provide controlled adult-use access to registered participants in selected cities and regions.
Slovenia
Medical and scientific cannabis frameworkSlovenia’s 2025 cannabis law expressly permits cannabis and natural THC for medical and scientific purposes under medicines, pharmacy, prescribing, and licensing rules.
Denmark
Permanent prescription medical cannabis programDenmark made its medicinal cannabis program permanent on 1 January 2026. Listed cannabis products can be prescribed by doctors and prepared and dispensed by pharmacies.
Ireland
Medical Cannabis Access Programme and ministerial licencesIreland’s Medical Cannabis Access Programme operates for specified conditions and products, alongside individual access under ministerial licence.
Italy
Prescription medical cannabis preparationsItalian doctors can prescribe pharmacy-compounded medical cannabis preparations, including standardized flower supplied through the national medical system.
Portugal
Authorized medical preparations dispensed by pharmaciesPortugal regulates the prescription and pharmacy dispensing of authorized medicines, preparations, and substances based on the cannabis plant.
Spain
Hospital-dispensed standardized medical preparationsSpain regulates standardized cannabis preparations for individually compounded medical formulas under the 2025 royal decree and the AEMPS registry.
United Kingdom
Specialist-prescribed cannabis-based medical productsCannabis-based products for medicinal use have been in Schedule 2 since 2018 and can be prescribed by eligible specialist doctors where clinically appropriate.
Poland
Prescription pharmacy medical cannabisMedical cannabis pharmaceutical raw material can be prescribed and prepared by pharmacies. Current rules require an in-person patient examination for this controlled prescription.
Greece
Prescription finished medical cannabis productsGreece permits controlled medical use and domestic production of finished pharmaceutical cannabis products for patient access.
Croatia
Prescription cannabinoid preparationsCroatia permits cannabinoid preparations for defined medical purposes and supplies authorized preparations on prescription.
Cyprus
Controlled medicinal cannabis office and patient channelCyprus maintains a medicinal cannabis regulatory office within Pharmaceutical Services and controls medical cannabis access through its medicines system.
North Macedonia
Licensed medical cannabis production and pharmacy productsNorth Macedonia licenses private medical cannabis cultivation and production and permits cannabis-based medical products through the regulated pharmaceutical market.
Norway
Named-patient medical accessA limited group of patients can receive approved cannabis medicines or unregistered cannabis products under a named-patient special permit.
Finland
Patient-specific special-permit accessFinland provides a patient-specific special-permit route for medicines without a standard marketing authorization, used for tightly controlled medical cannabis access.
Ukraine
Electronic-prescription medical cannabis frameworkUkraine permits cannabis circulation for medical purposes and has defined qualifying conditions, electronic prescriptions, pharmacy licensing, and product tracking.
Oceania
2 marketsAustralia
National medical access; limited private use in the ACTPatients can access unapproved medicinal cannabis through the Special Access Scheme or an Authorised Prescriber. The Australian Capital Territory separately permits limited adult possession and home growing, but not sale.
New Zealand
Prescription medicinal cannabis schemeNew Zealand’s Medicinal Cannabis Scheme sets quality standards and enables doctors to prescribe verified medicinal cannabis products.
Middle East
1 marketAsia
4 marketsIndia
State-licensed bhang and controlled AYUSH medicinesCannabis resin and flowering tops remain federally controlled, while cannabis-leaf bhang falls outside the NDPS Act definition and is sold under state excise licences in several states. Cannabis-containing AYUSH medicines require drug controls.
South Korea
Named-patient import of approved cannabis medicinesSouth Korea allows patients to apply for authorization and import specified cannabis-derived medicines that have been approved by an overseas medicines regulator.
Sri Lanka
Licensed Ayurvedic cannabis medicinesSri Lanka’s Ayurveda Code permits licensed entities and registered Ayurveda practitioners to obtain cannabis for manufacturing Ayurveda products and treating patients.
Thailand
Medical-only regulated cannabis accessThailand is restricting cannabis flower and preparations to medical and health use under licensed clinics, health facilities, herbal-product stores, and authorized traditional practitioners.
Africa
5 marketsMorocco
Emerging regulated medical cannabis marketMorocco regulates lawful medical, pharmaceutical, and industrial cannabis activity. National authorities report domestically marketed cannabis-derived products and are expanding clinical prescription guidance and product registration.
Mauritius
Hospital-dispensed medical cannabis programMauritius permits approved patients to receive medicinal cannabis through authorized specialists, a therapeutic committee, and trained pharmacists at regional hospitals.
Seychelles
Permit-based medical cannabis dispensingSeychelles has a statutory medical cannabis route covering applications, medical-practitioner duties, caregivers, import, and dispensing to approved patients.
Zimbabwe
Licensed medical production and registered cannabis medicinesZimbabwe licenses cannabis production for medical and scientific use, and the medicines regulator confirms that cannabis-containing complementary medicines have been registered.
South Africa
Private adult use protected; commercial dealing prohibitedAdults have constitutional protection for private cannabis use, possession, and cultivation. The Cannabis for Private Purposes Act provides the statutory framework, while commercial dealing remains prohibited.
Caucasus
1 marketLegal status is not product availability
First classify the law. Then verify the shelf.
A country page becomes a legal-market profile as soon as its access route is source-verified. Brand, product, pharmacy, association, and retailer pages are added only when VeedAtlas has enough first-party or regulator data to avoid thin and misleading SEO pages.